Imunon, Inc. (IMNN)
1.60
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
1.59
-0.01
(-0.62%)
After-Hours: 20:00
Imunon Free Cash Flow : -15.18M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.18M |
| March 31, 2026 | -15.06M |
| December 31, 2025 | -14.18M |
| September 30, 2025 | -14.95M |
| June 30, 2025 | -14.57M |
| March 31, 2025 | -16.11M |
| December 31, 2024 | -18.88M |
| September 30, 2024 | -18.22M |
| June 30, 2024 | -18.88M |
| March 31, 2024 | -21.22M |
| December 31, 2023 | -19.47M |
| September 30, 2023 | -20.81M |
| June 30, 2023 | -20.84M |
| March 31, 2023 | -19.51M |
| December 31, 2022 | -23.40M |
| September 30, 2022 | -23.41M |
| June 30, 2022 | -22.51M |
| March 31, 2022 | -19.70M |
| December 31, 2021 | -16.54M |
| September 30, 2021 | -15.16M |
| June 30, 2021 | -15.28M |
| March 31, 2021 | -15.52M |
| December 31, 2020 | -15.64M |
| September 30, 2020 | -17.53M |
| June 30, 2020 | -18.12M |
| Date | Value |
|---|---|
| March 31, 2020 | -19.91M |
| December 31, 2019 | -20.61M |
| September 30, 2019 | -8.999M |
| June 30, 2019 | -8.715M |
| March 31, 2019 | -8.176M |
| December 31, 2018 | -7.180M |
| September 30, 2018 | -17.39M |
| June 30, 2018 | -18.22M |
| March 31, 2018 | -18.21M |
| December 31, 2017 | -16.68M |
| September 30, 2017 | -17.13M |
| June 30, 2017 | -16.75M |
| March 31, 2017 | -16.83M |
| December 31, 2016 | -18.44M |
| September 30, 2016 | -17.67M |
| June 30, 2016 | -18.31M |
| March 31, 2016 | -19.73M |
| December 31, 2015 | -20.94M |
| September 30, 2015 | -23.82M |
| June 30, 2015 | -24.56M |
| March 31, 2015 | -22.45M |
| December 31, 2014 | -21.35M |
| September 30, 2014 | -17.96M |
| June 30, 2014 | -14.89M |
| March 31, 2014 | -16.16M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Phio Pharmaceuticals Corp. | -12.21M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 10.18B |
| Anika Therapeutics, Inc. | 0.562M |
| BioCryst Pharmaceuticals, Inc. | 356.23M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.026M |
| Cash from Investing (Quarterly) | -0.0691M |
| Cash from Financing (Quarterly) | 10.16M |
| Free Cash Flow Per Share (Quarterly) | -0.5914 |
| Free Cash Flow to Equity (Quarterly) | -10.03M |
| Free Cash Flow to Firm (Quarterly) | -3.017M |
| Free Cash Flow Yield | -230.4% |